MGI Partners with National Cancer Centre Singapore to Undergo Comprehensive Genomic Profiling of Asian-Prevalent Cancers

MGI Tech Singapore Pte, Ltd. (“MGI”), a company committed to building core tools and technology to lead life science, recently entered a research partnership with National Cancer Centre Singapore (“NCCS”) to facilitate comprehensive, multi-dimensional genomic profiling of Asian-prevalent cancers using MGI’s core DNBSEQ™ technology.

Meta-analysis uncovers stress-responsive genes in Arabidopsis

Plants can be temperamental. Even weeds along the side of highways or pushing their way up in the cracks of concrete sidewalks can get stressed

April 12, 2024

FDA Displeased With Companies Purposely Adding Sesame to More Foods

Encouraging food manufacturers to keep options for allergic consumers on the shelf, the FDA released updated draft guidance for reducing risks of cross-contamination and inaccurate

September 28, 2023

Short-chain fatty acids propionate and butyrate directly modify chromatin to regulate gene expression

Short-chain fatty acids influence gene regulation and chromatin accessibility, highlighting their role in colorectal cancer and normal cellular processes.

January 13, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.